Market Overview
Drug delivery devices are specific mechanisms for the delivery of drugs or therapeutic instruments through a particular route of treatment. Such devices are well-used as part of one or more medical treatments.
According to MarkNtel Advisors’ research report, “ Global Autoimmune Disorder Drug Delivery Devices Market Analysis, 2021,” the market is likely to grow at a CAGR of around 15.25% in the forecast period of 2021-26. It owes to the rapidly increasing adoption of advanced technology for the effective delivery of drugs to the target site. Besides, the surging use of these drug delivery devices helps reduce the chances of side effects by optimizing the drug present at the target site and minimizes the dose & associated side effects. Furthermore, it also helps lessen the overall product cost by lowering the amount of active pharmaceutical ingredients. Hence, with all these factors, the overall market growth is likely to propel in the forecast period.
Impact of COVID-19
The outbreak of the Covid-19 pandemic made a relatively positive impact on the Global Autoimmune Disorder Drug Delivery Devices Market. Although, industries across the globe were severely affected. Yet, the healthcare and medical sectors experienced robust growth amidst the pandemic. With the accelerated spread of the virus, the need for Drug Delivery Devices has been propelling exponentially. Still, the market had to face slight delays & limitations because of the imposition of lockdown & restrictions on logistics. However, the manufacturing of the devices is expanding robustly. Furthermore, with the gradual upliftment of lockdown and ease of norms, the Global Autoimmune Disorder Drug Delivery Devices Market shall increase its production & supply and experience rapid growth in the coming years.
Market Segmentation
Oral Inhalation to Attain the Largest Market Share
Based on the Inhalation, the Global Autoimmune Disorder Drug Delivery Devices Market includes a wide range of dosage forms like tablets, syrups, capsules, solutions & suspensions. This Oral Inhalation segment is more likely to attain the largest share in the forecast period and includes drug delivery products like films & tablets. Besides, the oral route is the most preferred route of administration in terms of ease of use, safety, cost, and drug stability. Additionally, inhalation drug delivery systems are well-favored for pulmonary conditions, such as asthma and Chronic Obstructive Pulmonary Disease (COPD). Furthermore, other factors like the growing prevalence of respiratory diseases & technological advancement of devices used for inhalation delivery shall also propel the segment with the largest share in the forecast period.
Home Care Settings to Dominate with the Fastest Growth
Amongst various end-users, the Home Care Settings segment dominated the Global Market with the fastest growth in the previous years and is likely to continue its dominance in the forecast period. It owes to prominent factors, such as the rapidly growing hospital-acquired infections, high cost, and longer wait times in hospitals. All these elements are increasing the trend of self-administration and better care at home. Hence, based on these factors, the segment is likely to continue its dominance & propel the overall market growth during the forecast period, states MarkNtel Advisors in their research report, “Global Autoimmune Disorder Drug Delivery Devices Market Analysis, 2021.”
Regional Landscape
Asia-Pacific to Attain the Largest Market Share
The Global Autoimmune Disorder Drug Delivery Devices Market is expanding exponentially throughout the world. Developed economies & favorable regulatory procedures are some of the prominent factors contributing toward the massive platform of opportunities for the market players. Out of all regions, Asia-Pacific is more likely to attain the largest share in the forecast period owing to rising economic growth. Besides, a large patient pool in countries like China, Japan, and India is another aspect leading to the adoption of drug delivery devices by various end-users. Furthermore, in countries like Japan, numerous drug delivery devices are coming into usage for delivering particular types of drugs. Hence, the surging adoption of advanced drug delivery devices in Asia-Pacific shall fuel the overall market growth in the forecast period.
Market Driver
The Global Autoimmune Disorder Drug Delivery Devices Market is likely to grow exponentially in the forecast period, owing to factors such as the rapidly increasing demand for drug delivery devices boosting the R&D field. Besides, the contribution by market players is continuously engaged in strategic alliances to acquire advanced technology for various applications. Several biotechnological companies are exploring its technology to develop a drug delivery device for a kidney. Furthermore, the surging adoption of drug delivery devices in home-care settings shall further increase the accessibility of these devices for patients and drive the market exponentially in the coming years.
Competitive Landscape
According to MarkNtel Advisors, the leading players in the Glfobal Autoimmune Disorder Drug Delivery Devices Market are Amgen Inc., AbbVie Inc., Bayer AG, Biogen Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., The Merck Group, Novartis International AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., UCB Pharma SA.
Key Questions Answered in the Market Research Report:
1. What are the overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of the Global Autoimmune Disorder Drug Delivery Devices Market?
2. What is the region-wise industry size, growth drivers, and challenges?
3. What are the key innovations, opportunities, current & future trends, and regulations in the Global Autoimmune Disorder Drug Delivery Devices Market?
4. Who are the key competitors, their key strengths & weaknesses, and how do they perform in the Global Autoimmune Disorder Drug Delivery Devices Market based on the competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the Global Autoimmune Disorder Drug Delivery Devices Market study?
Market Outlook, Segmentation, and Statistics
1. Impact of COVID-19 on Global Autoimmune Disorder Drug Delivery Devices Market
2. Market Size & Analysis
3. By Revenue
4. Market Share & Analysis
5. By Indication
a. Psoriasis
b. Rheumatoid Arthritis
c. Multiple Sclerosis
d. Inflammatory Bowel Diseases
e. Systemic Lupus Erythematosus
f. Diabetes Mellitus
g. Others (Guillain Barre Syndrome, Grave’s Disease, etc.)
6. By Product Type
a. Pen-Injectors
b. Auto-Injectors
c. Pre-Filled Syringes
d. Vials
7. By Manufacturing Type
a. In-House Manufacturing
b. Outsourced Manufacturing
8. By Region
a. North America Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
b. The US Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
c. Canada Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
d. South America Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
e. Brazil Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
f. Europe Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
g. The UK Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
h. Germany Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
i. France Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
j. Asia-Pacific Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
k. China Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
l. South Korea Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
m. Japan Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
n. The Middle East & Africa Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F (USD Million)
9. By Competitors
a. Competition Characteristics
b. Market Share & Analysis
c. Competitive Matrix
10. Global Autoimmune Disorder Drug Delivery Devices Market Hotspots & Opportunities
11. Global Autoimmune Disorder Drug Delivery Devices Market Regulations & Policy
12. Key Strategic Imperatives for Success and Growth
13. Global Competition Outlook
14. Competition Matrix
15. Company Profile